Allspring Global Investments Holdings LLC Takes Position in Smith & Nephew SNATS, Inc. (NYSE:SNN)

Allspring Global Investments Holdings LLC bought a new stake in shares of Smith & Nephew SNATS, Inc. (NYSE:SNN - Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 11,892 shares of the medical equipment provider's stock, valued at approximately $335,000.

A number of other institutional investors have also recently made changes to their positions in the company. Hara Capital LLC boosted its holdings in Smith & Nephew SNATS by 391.4% in the fourth quarter. Hara Capital LLC now owns 2,457 shares of the medical equipment provider's stock worth $60,000 after purchasing an additional 1,957 shares during the last quarter. US Bancorp DE boosted its holdings in Smith & Nephew SNATS by 21.8% in the fourth quarter. US Bancorp DE now owns 13,604 shares of the medical equipment provider's stock worth $334,000 after purchasing an additional 2,437 shares during the last quarter. Jones Financial Companies Lllp boosted its holdings in Smith & Nephew SNATS by 18.2% in the fourth quarter. Jones Financial Companies Lllp now owns 11,696 shares of the medical equipment provider's stock worth $287,000 after purchasing an additional 1,797 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in Smith & Nephew SNATS by 22.4% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 33,305 shares of the medical equipment provider's stock worth $819,000 after purchasing an additional 6,106 shares during the last quarter. Finally, Raymond James Financial Inc. purchased a new stake in Smith & Nephew SNATS in the fourth quarter worth approximately $4,992,000. Hedge funds and other institutional investors own 25.64% of the company's stock.

Smith & Nephew SNATS Stock Performance

SNN traded down $0.78 during trading on Friday, hitting $30.29. The company's stock had a trading volume of 1,285,641 shares, compared to its average volume of 823,769. The company has a quick ratio of 1.33, a current ratio of 2.89 and a debt-to-equity ratio of 0.62. Smith & Nephew SNATS, Inc. has a one year low of $23.69 and a one year high of $31.72. The firm has a market cap of $13.27 billion, a PE ratio of 14.02, a P/E/G ratio of 0.94 and a beta of 0.69. The business's 50 day simple moving average is $29.30 and its 200-day simple moving average is $27.42.

Wall Street Analysts Forecast Growth

SNN has been the topic of several research reports. Hsbc Global Res cut shares of Smith & Nephew SNATS from a "strong-buy" rating to a "hold" rating in a report on Friday, April 25th. HSBC cut shares of Smith & Nephew SNATS from a "buy" rating to a "hold" rating in a report on Friday, April 25th. Finally, Canaccord Genuity Group increased their price target on shares of Smith & Nephew SNATS from $27.00 to $28.00 and gave the stock a "hold" rating in a research report on Thursday, May 1st. Six research analysts have rated the stock with a hold rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $28.00.

About Smith & Nephew SNATS

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.